SSIM
HALO icon

Sheets Smith Investment Management’s Halozyme HALO Stock Holding History

Sheets Smith Investment Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$587K Buy
+11,896
New +$609K 0.64% 23
2022
Q2 		$510K Buy
+12,066
New +$522K 0.59% 29
2020
Q4 		$498K Buy
+11,671
New +$420K 0.45% 58

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sheets Smith Investment Management's HALO Position: Q4 2022 in Review

Sheets Smith Investment Management opened a new position in Halozyme (HALO) in Q4 2022: 11,896 shares worth $587K. The stake represents 0.64% of the portfolio and ranks #23 among its holdings. This is a return to the name: Sheets Smith Investment Management previously reported a position in HALO as recently as Q2 2022.

Sheets Smith Investment Management first reported a position in HALO in Q4 2020 and has held it in 3 quarters since. 423 funds tracked by Wall St. Rank hold HALO as of Q4 2022.

  • Sheets Smith Investment Management held 11,896 shares of Halozyme worth $587K as of Q4 2022.
  • Halozyme was a new Sheets Smith Investment Management position in Q4 2022.
  • Halozyme made up 0.64% of Sheets Smith Investment Management's portfolio in Q4 2022, its #23 holding.
  • Sheets Smith Investment Management first reported a position in Halozyme in Q4 2020 and has held it in 3 quarters since.
  • 423 funds tracked by Wall St. Rank held Halozyme as of Q4 2022.

Based on Sheets Smith Investment Management's 13F filing for Q4 2022, filed 10 Feb 2023.